greatgenes

What is a polygenic score

Many common conditions and traits are influenced by thousands of genetic variants, each with a tiny effect. A polygenic score adds these effects up into one number and compares it with other people. This page explains how such a score is calculated, how to read it, and why it is not a diagnosis.

What it is
a weighted sum of many small genetic effects, compared with a reference population
What it is not
a diagnosis, or the probability that you will get the condition
Scores in greatgenes
15 published scores from the PGS Catalog, weights used as published
Coverage threshold
a score is assessed only if your chip covers at least 50 % of it
Shown openly
results at least 1 standard deviation from the average
Reference population
European participants of 1000 Genomes (genotypes for published scores, allele frequencies for GWAS traits)

How a score is calculated

In short: for each variant in the score, count how many copies of the “effect” letter you have and multiply by the variant’s weight from a large study; then add everything up.

The weights come from genome-wide association studies, which compare large numbers of people, often hundreds of thousands, with and without a condition (or with different values of a trait such as cholesterol). Researchers publish the finished scores — the list of variants and their weights — in the PGS Catalog, where each has an identifier such as PGS000028.

greatgenes uses 15 published scores, chosen because consumer chips cover them well, with their published weights as they are: no weights of our own and no guessing of unmeasured positions. The calculation runs in your browser.

Percentile and z: how to read the result

In short: z says how many standard deviations your score is from the average of the reference population; the percentile is the share of that population expected to have a lower score.

The raw sum on its own means little, so it is compared with what is expected in a reference population. greatgenes uses the genomes of the European participants of 1000 Genomes: for published scores it computes the score for each of them on exactly the variants found in your file and takes the average and spread from these real values, so variants that are inherited together (for example in the HLA region) are not treated as independent. Your result is expressed as z (distance from the average in standard deviations) and as a percentile, assuming a normal distribution. Traits from the GWAS Catalog use European allele frequencies instead; there neighbouring variants are removed beforehand.

zPercentileWord in the report
at least +2about the 98th or higherwell above average
at least +1about the 84th or higherabove average
between −1 and +1between the 16th and the 84thnear average
at most −1about the 16th or lowerbelow average
at most −2about the 2nd or lowerwell below average

In the report, only results at least 1 standard deviation from the average (and with enough coverage) are shown openly. The rest are folded into “Details” under the table with a one-line count; the full table, sorted by distance from the average, is always there.

Coverage: how much of the score your chip reads

In short: if your chip misses too much of a score, the result is not given at all, rather than given wrongly.

No chip reads every variant of every score. greatgenes measures coverage as the share of the score’s variance that your chip’s positions explain, so a missing variant with a large weight counts for more than one with a tiny weight (Choi, Mak, O’Reilly 2020). Below 50 % the score is marked “not assessed” and no percentile is given.

Ancestry: who the scores were built on

In short: most genetic studies, and therefore most scores, are based on people of European ancestry. For people of other ancestries the scores are less accurate.

Scores for one sex

2 of the scores apply to one sex only: breast cancer (PGS000028, built on women) and prostate cancer (PGS000044). The score itself is calculated from the same kind of variants for everyone; what depends on sex is whether the result applies to you (Mavaddat et al. 2015; Schumacher et al. 2018).

Why a score is not a diagnosis

In short: a polygenic score tells you where you stand compared with other people, not whether you will get a condition.

Other limits of chip data: What a consumer DNA chip can and cannot tell you. The full rules of the report: How greatgenes works: polygenic scores and traits.

Analyse your file — in your browser, without uploading it.

References

  1. Lambert SA et al. The Polygenic Score Catalog as an open database for reproducibility and systematic evaluation. Nat Genet 2021. doi:10.1038/s41588-021-00783-5
  2. Choi SW, Mak TS, O’Reilly PF. Tutorial: a guide to performing polygenic risk score analyses. Nat Protoc 2020. doi:10.1038/s41596-020-0353-1
  3. Martin AR et al. Clinical use of current polygenic risk scores may exacerbate health disparities. Nat Genet 2019. doi:10.1038/s41588-019-0379-x
  4. Torkamani A, Wineinger NE, Topol EJ. The personal and clinical utility of polygenic risk scores. Nat Rev Genet 2018. doi:10.1038/s41576-018-0018-x
  5. Mavaddat N et al. Prediction of breast cancer risk based on profiling with common genetic variants. J Natl Cancer Inst 2015. doi:10.1093/jnci/djv036
  6. Schumacher FR et al. Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. Nat Genet 2018. doi:10.1038/s41588-018-0142-8